NCT03921814 is a NA clinical trial of Treatment with IPL device in Hair Removal, sponsored by Philips Healthcare.

Who is sponsoring NCT03921814?

NCT03921814 is sponsored by Philips Healthcare.

What drugs are being tested in NCT03921814?

Interventions in NCT03921814: Treatment with IPL device.

What condition does NCT03921814 study?

NCT03921814 studies Hair Removal.

Is NCT03921814 still recruiting?

NCT03921814 is currently completed. Last updated 20 October 2022.

Last reviewed 2022-10-20 · How we verify

NCT03921814

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Sunstone IPL (Intense Pulsed Light) for Hair Reduction

Completed NA Last updated 20 October 2022

What this trial tests

NA trial testing Treatment with IPL device in Hair Removal in 102 participants. Completed in 20 May 2022.

Timeline

11 April 2019

Primary endpoint
23 September 2021

20 May 2022

Quick facts

Lead sponsor	Philips Healthcare
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	102
Start date	11 April 2019
Primary completion	23 September 2021
Estimated completion	20 May 2022
Sites	2 locations across United States

Drugs / interventions tested

Treatment with IPL device

Conditions studied

Hair Removal — all drugs for Hair Removal →

Sponsor

Philips Healthcare — full company profile →

Who can join

Adults 18 to 65, female only, with Hair Removal. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective, multi-center, single-arm, single blinded study to evaluate the safety and efficacy of the Sunstone IPL (Intense Pulsed Light) device to remove hair.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Treatment with IPL device

Trials testing the same drug.

NCT03945383 — Clinical Investigation of Safety and Effectiveness of Emerald IPLdevice · NA · completed

Other Philips Healthcare trials

Trials by the same sponsor.

NCT03945383 — Clinical Investigation of Safety and Effectiveness of Emerald IPLdevice · NA · completed
NCT03901976 — ZeroFall - Reliability Testing of Optical Sensor to Detect Bed Exit for Patients in Hospital · NA · terminated
NCT03673566 — Clinical Evaluation of the "NICU Clinical Decision Support Dashboard" - CHMCO · NA · withdrawn
NCT03673579 — Clinical Evaluation of the "NICU Clinical Decision Support Dashboard" - MHSB · NA · withdrawn
NCT03642730 — Interactive Guided Ultrasound Examinations Done by Non-experts of Ultrasound Imaging · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03921814 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Philips Healthcare
Last refreshed: 20 October 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03921814.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing